Cogstate Ltd

CGS

Company Profile

  • Business description

    Cogstate Ltd is a cognitive science company. The principal activity of the group is the Creation, validation, and commercialisation of digital brain health assessments; and the Design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments and reporting. Its operating segment includes Clinical Trials, Healthcare, and Administration. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.

  • Contact

    367 Collins Street
    Level 32
    MelbourneVIC3000
    AUS

    T: +61 396641300

    https://www.cogstate.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Health Information Services

    Fiscal Year End

    30 June 2026

    Employees

    249

Stocks News & Analysis

stocks

10 best global blue-chip stocks to buy for the long term

The stocks of these high-quality companies with large market capitalizations look undervalued today.
stocks

3 overvalued ASX shares going into earnings

Prices of these shares exceed our Fair Value Estimate by more than double.
stocks

The long-term case for compounders

Compounders tend to deliver steadier, more durable profit growth across full cycles, making them better suited for long-term investors.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,068.8042.20-0.46%
CAC 408,181.8855.350.68%
DAX 4024,753.03214.220.87%
Dow JONES (US)49,112.97220.500.45%
FTSE 10010,321.4697.920.96%
HKSE26,775.57611.54-2.23%
NASDAQ23,507.9546.130.20%
Nikkei 22552,655.18667.67-1.25%
NZX 50 Index13,412.4410.74-0.08%
S&P 5006,953.5914.560.21%
S&P/ASX 2008,778.6042.50-0.48%
SSE Composite Index4,015.75102.20-2.48%

Market Movers